SCHEMBL4098788

SCHEMBL4098788

O=C(O)[C@@H]1CCC2OC2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TFPI2 P48307 5/20 0.52
LMNA P02545 2/20 0.52
KDM4E B2RXH2 1/20 0.52
GMNN O75496 1/20 0.52
PMP22 Q01453 1/20 0.52
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
THPO P40225 1/20 0.52
ACE P12821 1/20 0.41
PPM1B O75688 2/20 0.39
PTPN1 P18031 2/20 0.39
PPP1CC P36873 2/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C1 Q04828 1/20 0.39
GABRR1 P24046 1/20 0.39
PPP5C P53041 2/20 0.38
PPP2CA P67775 1/20 0.38
NPY4R P50391 1/20 0.38
PLG P00747 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184711 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4088843 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4359618 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4948347 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL7263479 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL2726787 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4109815 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL124941 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL2184024 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL27976167 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227789-A1 ETHYLENEDIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227789-A1 ETHYLENEDIAMINE DERIVATIVES F2, ECE1, MLLT1 TFPI2 1023/4885LMNA 814/4885KDM4E 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.